These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9651605)

  • 1. Concentration of levofloxacin in cervical mucus and its clinical effects on cervicitis.
    Chimura T; Arai M; Onuma Y; Oda T; Kawagoe S; Kunii K; Saito T; Saito N; Sato F; Numazaki M; Matsuo M; Murayama K; Morizaki N
    Jpn J Antibiot; 1997 Nov; 50(11):871-7. PubMed ID: 9651605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequate levofloxacin treatment schedules for uterine cervicitis caused by Chlamydia trachomatis.
    Mikamo H; Sato Y; Hayasaki Y; Hua YX; Tamaya T
    Chemotherapy; 2000; 46(2):150-2. PubMed ID: 10671767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of levofloxacin once-a-day therapy on uterine cervicitis].
    Mikamo H; Sato Y; Hayasaki Y; Tamaya T; Yamada Y; Ito K; Izumi K; Kawazoe K
    Jpn J Antibiot; 1999 Jul; 52(7):511-6. PubMed ID: 10516931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of levofloxacin 500 mg qd in the treatment of cervicitis and intrauterine infections caused by Chlamydia trachomatis].
    Mikamo H; Yamagishi Y; Takahashi K; Izumi K; Hoshina S; Nakabe K; Fujiwara M; Yoshimura M; Ando Y; Kurashima M; Kinoshita C; Yoshioka M
    Jpn J Antibiot; 2011 Aug; 64(4):217-29. PubMed ID: 22066346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute nongonococcal epididymitis--pharmacological and therapeutic aspects of levofloxacin].
    Saito I; Suzuki A; Saiko Y; Yokozawa M; Ono K; Miyata K; Miyamura R; Hamaya O; Kaneko K; Yamamoto T
    Hinyokika Kiyo; 1992 May; 38(5):623-8. PubMed ID: 1609677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levofloxacin in obstetrics and gynecology].
    Chimura T; Morisaki N; Funayama T; Oda T
    Jpn J Antibiot; 1992 May; 45(5):585-91. PubMed ID: 1512945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ofloxacin in the treatment of mucopurulent cervicitis: response of chlamydia-positive and chlamydia-negative forms.
    Chandeying V; Sutthijumroon S; Tungphaisal S
    J Med Assoc Thai; 1989 Jun; 72(6):331-7. PubMed ID: 2778422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of antibody titers to chlamydial infection and effects of levofloxacin in cystic cervicitis and chlamydial infection].
    Chimura T
    Jpn J Antibiot; 1997 May; 50(5):479-84. PubMed ID: 9212369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic and clinical evaluation of levofloxacin in obstetrics and gynecology].
    Cho N; Araki H; Kimura T; Shimizu A; Ichikawa K; Fukunaga K; Kunii K
    Jpn J Antibiot; 1992 Mar; 45(3):270-84. PubMed ID: 1512924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections].
    Tanimura H; Ohnishi H; Okamura T; Uenishi M; Ichimiya G; Kobayashi Y; Aoki Y; Oka S; Yamamoto S; Shimada K
    Jpn J Antibiot; 1992 May; 45(5):557-68. PubMed ID: 1512942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory and clinical studies on levofloxacin].
    Tanaka K; Iwamoto M; Maesaki S; Koga H; Kohno S; Hara K; Sugawara K; Kaku M; Kusano S; Sakito O
    Jpn J Antibiot; 1992 May; 45(5):548-56. PubMed ID: 1512941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint].
    Fujita A; Miya T; Tanaka R; Hirayama S; Isaka H; Ono Y; Koshiishi Y; Goya T
    Jpn J Antibiot; 1999 Nov; 52(11):661-6. PubMed ID: 10659442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of ofloxacin in sexually transmitted male urethritis and cervicitis].
    Kumamoto Y; Sakai S; Hirose T; Tsunekawa T; Machida T; Kiyota H; Okazaki T; Kishi H; Higashihara E; Aso Y
    Jpn J Antibiot; 1988 Oct; 41(10):1445-79. PubMed ID: 3144614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sputum penetration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections].
    Nakamori Y; Tsuboi E; Narui K; Nakatani T; Nakata K; Sugi H
    Jpn J Antibiot; 1992 May; 45(5):539-47. PubMed ID: 1512940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic and clinical evaluation of levofloxacin in obstetrical and gynecological field].
    Matsuda S; Oh K; Hirayama H
    Jpn J Antibiot; 1992 Mar; 45(3):285-92. PubMed ID: 1512925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin levels in cervical mucus and plasma after a single 1.0g oral dose for chlamydial cervicitis.
    Worm AM; Osterlind A
    Genitourin Med; 1995 Aug; 71(4):244-6. PubMed ID: 7590717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of levofloxacin to non-gonorrheal urethritis].
    Onodera S; Onoe Y; Hosobe T; Kato T; Yoshida M
    Jpn J Antibiot; 2012 Dec; 65(6):399-409. PubMed ID: 23593735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on the concentrations of levofloxacin in the gallbladder tissue and bile of patients].
    Hukagawa H; Noga K
    Jpn J Antibiot; 1992 Mar; 45(3):253-7. PubMed ID: 1512921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological and clinical studies on levofloxacin in male gonococcal urethritis].
    Saito I; Suzuki A; Saiko Y; Yokozawa M; Ono K
    Hinyokika Kiyo; 1992 May; 38(5):629-32. PubMed ID: 1609678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro analysis of the change in resistance of Chlamydia trachomatis under exposure to sub-MIC levofloxacin for a therapeutic term.
    Takahashi S; Hagiwara T; Shiga S; Takaoki Hirose T; Tsukamoto T
    Chemotherapy; 2000; 46(6):402-7. PubMed ID: 11053906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.